The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations.

  title={The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations.},
  author={Noreen Dadirai Mdege and Nick Meader and Charlie Lloyd and Steve Parrott and Jim Mccambridge},
  journal={Public Health Research},
Background Although illegal drug use has largely been declining in the UK over the past decade, this period has witnessed the emergence of a range of novel psychoactive substances (NPS) (‘legal highs’). These are new, mostly synthetic, substances that mimic the effects of existing drugs). Despite there being many causes for concern in relation to NPS, there has been little prior study of the burden associated with their use in public health terms. Clarity is lacking on research priorities in… 
The public health evidence-base on novel psychoactive substance use: scoping review with narrative synthesis of selected bodies of evidence
This review addressed what was known about the public health burden associated with novel psychoactive substances (NPS) use, and the effectiveness of responses targeting NPS use and/or associated problems, and found the available evidence to be at an early stage of development.
Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016
Reporting of deaths following NPS use has risen despite introduction of the PSA, and additional approaches to prohibition are needed to curb their persistence in deprived demographics.
Evidence for public health on novel psychoactive substance use: a mixed-methods study
Novel psychoactive substances (NPSs) contribute to the public health impact of substance misuse. This report provides research evidence addressing 11 research questions related to NPSs, covering
New/emerging psychoactive substances and associated psychopathological consequences
An updated review of both the large number of new/novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences and the ever-increasing changes in terms of recreational psychotropics' availability is provided.
New psychoactives within polydrug use trajectories—evidence from a mixed‐method longitudinal study
In Northern Ireland, new psychoactive substances appear to be a feature of broader polydrug use rather than a standalone class of drug use.
Trends in Mortality From Novel Psychoactive Substances as “Legal Highs”: Gender Differences in Manner of Death and Implications for Risk Differences for Women
Where NPS have been used, differences in drug death profiles are less likely to be accounted for by gender than other demographic or behavioral differences more typically found in opiate deaths.
Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients
The use of psychoactive substances was characterized by poly-use of both traditional and novel substances, with several psychopathological consequences, and a positive association with a lifetime diagnosis of bipolar disorder was found.
Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids
The findings have shown the great capacity of NPCC to monitor NPS abuse in Serbia, reliably detect SCs in illicit products and biological samples, and clinically manage the adverse effects in their users.
Responding to a new wave of high potency synthetic cannabinoids.
It is proposed that an early warning drug system should aim to go beyond enhanced toxicological analysis to identify new psychoactive compounds and address the equally important challenges of informing a risk profi le for the drugs detected and developing an engagement system to disseminate risk information about new drugs to health professionals and community workers, and indeed users themselves.
Understanding increasing rates of psychiatric hospital detentions in England: development and preliminary testing of an explanatory model
The logic model highlights likely contributory factors to the rise in detentions in England, priorities for future research and potential policy targets for reducingdetentions.


New psychoactive substances in England: a review of the evidence.
This report builds on chapter 2 of the report of the expert panel review, and provides an overview of the current available evidence on New Psychoactive Substances, although there are gaps in the evidence on the prevalence of use and total measure of NPS use.
New psychoactive substances legislation in Ireland - Perspectives from academia.
Irish controlled drugs legislation and drug enforcement policies as enacted in recent years and their effects on academic research on NPS are examined, finding that it is administratively challenging to perform scientific research on controlled substances at academic institutions.
Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill.
It is appropriate at this time for other governments to assess more fully the nature of the NPS problem, and the potential control approaches.
Diffusion of New Psychoactive Substances: understanding population motives, harms and intervention needs
The key reason for the diffusion of an NPS was found to be the psychopharmacological effects of a product, and there should also be an acknowledgment of the importance of friendship networks, and increasingly online forums.
‘Legal Highs’: The Challenge of New Psychoactive Substances
This paper aims to set out some of the policy and public health issues raised by the appearance of a wide range of emergent psychoactive substances of diverse origin, effect and risk profile
New psychoactive substances and British drug policy: A view from the cyber-psychonauts
Abstract Aims: (i) To collect data on the consumption patterns, purchase patterns and motivations of the online NPS community, and (ii) engage this specific group of NPS users in an exploration of
Novel Psychoactive Substances (NPS): a Study on Persian Language Websites
The availability of online marketing of NPS in Persian language websites may constitute a public health challenge at least across three Farsi-speaking countries in the Middle East.
NPS: Medical Consequences Associated with Their Intake.
The present chapter aims at providing an overview of the clinical and pharmacological issues relating to these most popular NPS categories, including synthetic cathinones, synthetic cannabinoids, and psychedelics/phenethylamines.
Emerging drugs in Europe
In the last few years, there has been a rapid increase in the number of NPS launched on the European drugs market and some of these new substances has been detected through surveys/questionnaires, studies in drug samples and biological fluids, and case reports and NPS-induced fatalities.